Search Results - "Koek, Ger H"

Refine Results
  1. 1

    Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology by Liang, Wen, Menke, Aswin L, Driessen, Ann, Koek, Ger H, Lindeman, Jan H, Stoop, Reinout, Havekes, Louis M, Kleemann, Robert, van den Hoek, Anita M

    Published in PloS one (23-12-2014)
    “…The recently developed histological scoring system for non-alcoholic fatty liver disease (NAFLD) by the NASH Clinical Research Network (NASH-CRN) has been…”
    Get full text
    Journal Article
  2. 2

    The potential of flavonoids in the treatment of non-alcoholic fatty liver disease by Van De Wier, Bregje, Koek, Ger H., Bast, Aalt, Haenen, Guido R. M. M.

    “…The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) comprises multiple parallel pathways with a dynamic cross talk that…”
    Get full text
    Journal Article
  3. 3

    Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment by Heyens, Leen J M, Busschots, Dana, Koek, Ger H, Robaeys, Geert, Francque, Sven

    Published in Frontiers in medicine (14-04-2021)
    “…An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going…”
    Get full text
    Journal Article
  4. 4

    Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis by De Munck, Toon J. I., Xu, Pan, Verwijs, Harm J. A., Masclee, Ad A. M., Jonkers, Daisy, Verbeek, Jef, Koek, Ger H.

    Published in Liver international (01-12-2020)
    “…Background The gut‐liver axis is considered to play a critical role in the development and progression of nonalcoholic fatty liver disease (NAFLD). The…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins by Walenbergh, Sofie M.A, Koek, Ger H, Bieghs, Veerle, Shiri-Sverdlov, Ronit

    Published in Journal of hepatology (01-04-2013)
    “…Summary Non-alcoholic steatohepatitis (NASH) is hallmarked by lipid accumulation in the liver (steatosis) along with inflammation (hepatitis). The transition…”
    Get full text
    Journal Article
  7. 7

    A Multicenter, Randomized Efficacy Study of the EndoBarrier Gastrointestinal Liner for Presurgical Weight Loss Prior to Bariatric Surgery by SCHOUTEN, Ruben, RIJS, Carianne S, BOUVY, Nicole D, HAMEETEMAN, Wim, KOEK, Ger H, JANSSEN, Ignace M. C, GREVE, Jan-Willem M

    Published in Annals of surgery (01-02-2010)
    “…The endoscopically placed duodenal-jejunal bypass sleeve or EndoBarrier Gastrointestinal Liner has been designed to achieve weight loss in morbidly obese…”
    Get full text
    Journal Article
  8. 8

    Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients by Yagmur, Eray, Sckaer, Johanna Hermine, Koek, Ger H, Weiskirchen, Ralf, Trautwein, Christian, Koch, Alexander, Tacke, Frank

    Published in Journal of translational medicine (12-12-2019)
    “…Mid-regional pro atrial natriuretic peptide (MR-proANP) is an established biomarker for heart failure, based on its key role in regulating homeostasis of water…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature by Pijls, Kirsten E., Jonkers, Daisy M. A. E., Elamin, Elhaseen E., Masclee, Ad A. M., Koek, Ger H.

    Published in Liver international (01-11-2013)
    “…Recent evidence suggests that translocation of bacteria and bacterial products, such as endotoxin from the intestinal lumen into the systemic circulation is a…”
    Get full text
    Journal Article
  11. 11

    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis by Kremers, Romy M W, Kleinegris, Marie-Claire, Ninivaggi, Marisa, de Laat, Bas, Ten Cate, Hugo, Koek, Ger H, Wagenvoord, Rob J, Hemker, H Coenraad

    Published in PloS one (04-05-2017)
    “…Impaired coagulation factor synthesis in cirrhosis causes a reduction of most pro- and anticoagulant factors. Cirrhosis patients show no clear bleeding or…”
    Get full text
    Journal Article
  12. 12

    Butyrate-induced transcriptional changes in human colonic mucosa by Vanhoutvin, Steven A L W, Troost, Freddy J, Hamer, Henrike M, Lindsey, Patrick J, Koek, Ger H, Jonkers, Daisy M A E, Kodde, Andrea, Venema, Koen, Brummer, Robert J M

    Published in PloS one (25-08-2009)
    “…Fermentation of dietary fiber in the colon results in the production of short chain fatty acids (mainly propionate, butyrate and acetate). Butyrate modulates a…”
    Get full text
    Journal Article
  13. 13

    Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease? by De Munck, Toon J I, Boesch, Markus, Verhaegh, Pauline, Masclee, Ad A M, Jonkers, Daisy, van Pelt, Jos F, du Plessis, Johannie, Korf, Hannelie, Nevens, Frederik, Koek, Ger H, Van der Merwe, Schalk, Verbeek, Jef

    Published in PloS one (14-05-2021)
    “…Neuregulin 4 (Nrg4), a novel adipokine enriched in brown adipose tissue has been observed to negatively regulate de novo hepatic lipogenesis and limit…”
    Get full text
    Journal Article
  14. 14

    Myosteatosis in nonalcoholic fatty liver disease: An exploratory study by De Munck, Toon J.I., Verhaegh, Pauline, Lodewick, Toine, Bakers, Frans, Jonkers, Daisy, Masclee, Ad.A.M., Verbeek, Jef, Koek, Ger H.

    “…•Fat infiltration in skeletal muscle (myosteatosis) may contribute to the development of insulin resistance and NAFLD.•The muscle fat and hepatic fat fraction…”
    Get full text
    Journal Article
  15. 15

    Myosteatosis in NAFLD patients correlates with plasma Cathepsin D by Ding, Lingling, De Munck, Toon. J. I., Oligschlaeger, Yvonne, dos Reis, Inês Magro, Verbeek, Jef, Koek, Ger. H., Houben, Tom, Shiri-Sverdlov, Ronit

    Published in Biomolecular concepts (01-01-2021)
    “…Previously, we have shown that hepatic lipid accumulation induces the secretion of cathepsin D (CTSD), and that plasma CTSD levels are associated with…”
    Get full text
    Journal Article
  16. 16

    Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation by Bieghs, Veerle, Walenbergh, Sofie M. A., Hendrikx, Tim, van Gorp, Patrick J., Verheyen, Fons, Olde Damink, Steven W., Masclee, Ad A., Koek, Ger H., Hofker, Marten H., Binder, Christoph J., Shiri-Sverdlov, Ronit

    Published in Liver international (01-08-2013)
    “…Background & Aims Non‐alcoholic steatohepatitis (NASH) is characterized by steatosis and inflammation. The transition from steatosis towards NASH represents a…”
    Get full text
    Journal Article
  17. 17

    Elevated citrate levels in non-alcoholic fatty liver disease: The potential of citrate to promote radical production by van de Wier, Bregje, Balk, Jiska M., Haenen, Guido R.M.M., Giamouridis, Dimosthenis, Bakker, Jaap A., Bast, Bertine C., den Hartog, Gertjan J.M., Koek, Ger H., Bast, Aalt

    Published in FEBS letters (02-08-2013)
    “…•Citrate levels are elevated in patients with non-alcoholic fatty liver disease.•Intracellular citrate levels are elevated upon exposure to an excess of fatty…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients by Ding, Lingling, De Munck, Toon. J. I., Oligschlaeger, Yvonne, Verbeek, Jef, Koek, Ger. H., Houben, Tom, Shiri-Sverdlov, Ronit

    Published in Biomolecular concepts (01-01-2021)
    “…Previous studies associated plasma cathepsin D (CTSD) activity with hepatic insulin resistance in overweight and obese humans. Insulin resistance is a major…”
    Get full text
    Journal Article